DBS candidates that fall short on a levodopa challenge test: Alternative and important indications

Neurologist

Volumn 17, Issue 5, 2011, Pages 263-268

  Morishita, Takashi ^a,b   Rahman, Maryam ^a   Foote, Kelly D ^a   Fargen, Kyle M ^a   Jacobson, Charles E ^b   Fernandez, Hubert H ^c   Rodriguez, Ramon L ^b   Malaty, Irene A ^b   Bowers, Dawn ^b   Hass, Christopher J ^d   Katayama, Yoichi ^e,f   Yamamoto, Takamitsu ^e,f   Okun, Michael S ^a,b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c McKnight Brain Institute   (United States)

^d Department of Neurological Surgery ^*  (United States)

^e NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f LERNER RESEARCH INSTITUTE   (United States)

Author keywords

deep brain stimulation; dyskinesia; levodopa challenge test; on off motor fluctuations; Parkinson disease; quality of life; tremor

Indexed keywords

CARBIDOPA PLUS LEVODOPA; LEVODOPA;

ADULT; ARTICLE; BRAIN DEPTH STIMULATION; BRAIN HEMORRHAGE; CLINICAL ASSESSMENT; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; DATA BASE; DETERIORATION; DEVICE; DISEASE DURATION; DISEASE SEVERITY; DRUG RECHALLENGE; DYSKINESIA; FEMALE; FOLLOW UP; HEMIPARESIS; HUMAN; IMPLANTABLE PULSE GENERATOR; MAJOR CLINICAL STUDY; MALE; MEDICATION REFRACTORY TREMOR; MENTAL DEFICIENCY; MINI MENTAL STATE EXAMINATION; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NEUROIMAGING; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; ON OFF MOTOR FLACTUATION; OUTCOME ASSESSMENT; PARKINSON DISEASE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUALITY OF LIFE; SEROMA; TREATMENT RESPONSE; UNIFIED PARKINSON DISEASE RATING SCALE;

AGED; ANTIPARKINSON AGENTS; COMBINED MODALITY THERAPY; DEEP BRAIN STIMULATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; QUALITY OF LIFE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 80052631689     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/NRL.0b013e31822d1069     Document Type: Article

References (29)

1. Anderson VC, Burchiel KJ, Hogarth P, et al. Pallidal versus subthalamic nucleus deep brain stimulation in Parkinson disease. Arch Neurol. 2005;62:554-560. (Pubitemid 40489885)
2. Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med. 2006;355:896-908. (Pubitemid 44315982)
3. Group TD-BSfPDS. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med. 2001;345:956-963.
4. Kleiner-Fisman G, Herzog J, Fisman DN, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord. 2006;21:S290-S304. (Pubitemid 44028288)
5. Krack P, Batir A, Van Blercom N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med. 2003;349:1925-1934. (Pubitemid 37409709)
6. Limousin P, Krack P, Pollak P, et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med. 1998;339:1105-1111. (Pubitemid 28465758)
7. Okun MS, Fernandez HH, Wu SS, et al. Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial. Ann Neurol. 2009;65:586-595.
8. Defer GL, Widner H, Marie RM, et al. Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Disord. 1999;14:572-584. (Pubitemid 30011449)
9. Lang AE, Houeto JL, Krack P, et al. Deep brain stimulation: preoperative issues. Mov Disord. 2006;21:S171-S196. (Pubitemid 44028281)
10. Lopiano L, Rizzone M, Bergamasco B, et al. Deep brain stimulation of the subthalamic nucleus in PD: an analysis of the exclusion causes. J Neurol Sci. 2002;195:167-170. (Pubitemid 34202295)
11. Pinter MM, Alesch F, Murg M, et al. Apomorphine test: a predictor for motor responsiveness to deep brain stimulation of the subthalamic nucleus. J Neurol. 1999;246:907-913. (Pubitemid 29512160)
12. Rodriguez RL, Fernandez HH, Haq I, et al. Pearls in patient selection for deep brain stimulation. Neurologist. 2007;13:253-260. (Pubitemid 47396311)
13. Langston JW, Widner H, Goetz CG, et al. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord. 1992;7:2-13.
14. Peto V, Jenkinson C, Fitzpatrick R, et al. The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res. 1995;4:241-248.
15. Okun MS, Tagliati M, Pourfar M, et al. Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers. Arch Neurol. 2005;62:1250-1255. (Pubitemid 41168352)
16. Krack P, Pollak P, Limousin P, et al. From off-period dystonia to peak-dose chorea: the clinical spectrum of varying subthalamic nucleus activity. Brain. 1999;122:1133-1146. (Pubitemid 29533128)
17. Katayama Y, Kasai M, Oshima H, et al. Subthalamic nucleus stimulation for Parkinson disease: benefits observed in levodopaintolerant patients. J Neurosurg. 2001;95:213-221. (Pubitemid 32799742)
18. Lyons KE, Davis JT, Pahwa R. Subthalamic nucleus stimulation in Parkinson's disease patients intolerant to levodopa. Stereotact Funct Neurosurg. 2007;85:169-174. (Pubitemid 46871898)
19. Melamed E, Bitton V, Zelig O. Episodic unresponsiveness to single doses of L-dopa in parkinsonian fluctuators. Neurology. 1986;36:100-103. (Pubitemid 16186061)
20. Hauser RA, Deckers F, Lehert P. Parkinson's disease home diary: further validation and implications for clinical trials. Mov Disord. 2004;19:1409-1413. (Pubitemid 40104047)
21. Hauser RA, Friedlander J, Zesiewicz TA, et al. A home diary to assess functional status in patients with Parkinson's disease with motor fluctuations and dyskinesia. Clin Neuropharmacol. 2000; 23:75-81. (Pubitemid 30212216)
22. Hauser RA, Russ H, Haeger DA, et al. Patient evaluation of a home diary to assess duration and severity of dyskinesia in Parkinson disease. Clin Neuropharmacol. 2006;29:322-330. (Pubitemid 44729943)
23. Vingerhoets FJ, Villemure JG, Temperli P, et al. Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up. Neurology. 2002;58:396-401. (Pubitemid 34150913)
24. Welter ML, Houeto JL, Tezenas du Montcel S, et al. Clinical predictive factors of subthalamic stimulation in Parkinson's disease. Brain. 2002;125:575-583. (Pubitemid 34194412)
25. Schupbach WM, Chastan N, Welter ML, et al. Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. J Neurol Neurosurg Psychiatry. 2005;76:1640-1644. (Pubitemid 41697626)
26. Okun MS, Rodriguez RL, Mikos A, et al. Deep brain stimulation and the role of the neuropsychologist. Clin Neuropsychol. 2007;21:162-189. (Pubitemid 46277802)
27. Moro E, Lozano AM, Pollak P, et al. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord. 2010.
28. Okun MS, Green J, Saben R, et al. Mood changes with deep brain stimulation of STN and GPi: results of a pilot study. J Neurol Neurosurg Psychiatry. 2003;74:1584-1586.
29. Fraix V, Pollak P, Moro E, et al. Subthalamic nucleus stimulation in tremor dominant parkinsonian patients with previous thalamic surgery. J Neurol Neurosurg Psychiatry. 2005;76: 246-248. (Pubitemid 40143716)